Delivery Order SPE2DB22D1041-SPE2DB25FUCB1
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $92K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $22,154.31 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Dupixent 300 mg/2 ml pens. This firm fixed price, competitively awarded contract is a non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,518.88 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Dupixent 300 mg/2 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 15, 2025, and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,770.06 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 12, 2025. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and distribution hub for federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,141.94 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $46,171.82 for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $32,001.89 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on July 29, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of July 30, 2025 represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The pharmaceutical distributor will perform this...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $51,903.30 on June 16, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml) under a firm fixed price contract with no set-aside designation. The contract is scheduled for completion by June 17, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $19,042.85 to supply Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $86,474.81 for Dupixent 300mg/2mL (2 units) under a firm fixed price contract with the Defense Logistics Agency Medical Supply Chain. The award was made on August 22, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,617.14 by the Defense Logistics Agency on September 11, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...